MAPT and Parkinson disease: Wang et al., in their narrative review, observed that animal models and recent clinical trials have shown that antibodies targeting α-syn have been effective in immunotherapy, as α-syn contributes to the fibrillization of Tau and also forms the LBs in the brain characteristic of PD.